GlassScriptPhysician profile
Christian Roehmer
NPI 1720643810
$10,784.57
in general payments reported to CMS, 2019-2025
18 companies · $6,243 in 2025
The $6,243 reported for 2025 was more than what 96% of Pain Medicine (Physical Medicine & Rehabilitation) providers received nationally (typical 2025 total: $400).
See the full distribution for Pain Medicine (Physical Medicine & Rehabilitation)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $527 · 2024: $4,015 · 2025: $6,243.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $5,982 · Food and Beverage: $4,803.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $5,981.62 |
| Food and Beverage | $4,802.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,782.90 | 2023-2025 | Intellis Adaptivestim, Vanta Adaptivestim, Inceptiv |
| Boston Scientific Corporation | $1,427.15 | 2024-2025 | Intracept |
| Spinal Simplicity, LLC | $1,317.08 | 2025 | Ha Minuteman G3-R, Liberty Si, Patriot Si |
| Stryker Corporation | $1,069.90 | 2024-2025 | Spinejack |
| Abbott Laboratories | $971.08 | 2024-2025 | Proclaim |
| Pacira Pharmaceuticals Incorporated | $865.50 | 2025 | Iovera |
| Spr Therapeutics, INC | $454.37 | 2023-2025 | Sprint Pns System |
| Nevro Corp. | $437.75 | 2024 | Senza |
| Saluda Medical Americas, INC. | $390.13 | 2024-2025 | Evoke |
| Averitas Pharma INC. | $269.92 | 2024-2025 | Qutenza |
| Vertos Medical, INC. | $222.52 | 2024 | Mild Device Kit |
| Abbvie INC. | $158.50 | 2024-2025 | |
| Forte Bio-Pharma LLC | $153.24 | 2024-2025 | Prolate, Nalocet, Tanlor |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $104.79 | 2025 | Relistor |
| Tonix Medicines, INC. | $95.99 | 2025 | Tonmya |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $25.02 | 2025 | |
| Scilex Pharmaceuticals INC. | $22.33 | 2025 | |
| Valinor Pharma, LLC | $16.40 | 2025 | Movantik |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christian Roehmer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.